New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production.
Read the December Issue of EMERGENCY Magazine
We want to tell you more about how EMERGENCY has been responding to the COVID-19 pandemic, not only keeping its healthcare facilities open, but also helping vulnerable communities with socio-economic support.
Read the December issue of our magazine for a closer look at EMERGENCY’s work during these difficult times, told to you by our colleagues around the world.
Click on the picture below:
Related Posts
